Fundraising Fox
Moderna
Cambridge, US · Founded 2016 · 6,242 employees on LinkedIn · 12 known investors
Find your way into Moderna
Sign up to see every warm intro you have to Moderna
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moderna team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
Founders & leadership
Moderna was founded in 2016 by Robert Langer and Noubar Afeyan, Ph.D..
Board
Investors · 12
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Blackstone Life Sciences's portfolio page · Not right? Tell us
How we know: Flagship Pioneering's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Khosla Ventures's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Three Fields Capital Management LLC's portfolio page · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements$1B disclosed across 3 of 5 rounds · 2013–2026
- Undisclosed amountconvertible notesAug 2026Source ↗
▶$451.4MraisedAug 2016 · 72 investors · BiotechnologyRule 506(b)
- Lorence KimExecutive Officer
- Stephane BancelExecutive Officer, Director
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- James R. KasingerExecutive Officer
- Elizabeth NabelDirector
- Stephen HogeExecutive Officer
- Henri TermeerDirector
- Noubar AfeyanDirector
- Lee BabissDirector
- Offering amount
- $600M
- Amount sold
- $451.4M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$446.1MraisedJan 2015 · 43 investors · PharmaceuticalsRule 506(b)
- Stephane BancelExecutive Officer, Director
- Lorence KimExecutive Officer
- James KasingerExecutive Officer
- Noubar AfeyanDirector
- Lee BabissDirector
- Robert CarpenterDirector
- Theo Melas-KyriaziDirector
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- Henri TermeerDirector
- Offering amount
- $502.2M
- Amount sold
- $446.1M
- First sale
- Dec 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$135MraisedJan 2014 · 40 investors · PharmaceuticalsRule 506(b)
- Henri TermeerDirector
- Lee BabissDirector
- Theo Melas-KyriaziDirector
- Robert CarpenterDirector
- John MendleinDirector
- Robert LangerDirector
- Noubar AfeyanDirector
- Stephane BancelExecutive Officer, Director
- Peter HuttDirector
- Offering amount
- $135M
- Amount sold
- $135M
- First sale
- Nov 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Moderna mafia →10 people who came through Moderna went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Moderna.
Frequently asked questions
- What does Moderna do?
- Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
- Who founded Moderna?
- Moderna was founded by Robert Langer, Noubar Afeyan, Ph.D. in 2016.
- Who are Moderna's investors?
- Moderna's investors include Aglae Ventures, Blackstone Life Sciences, Flagship Pioneering, FPV, Khosla Ventures, Lingotto, Premji Invest, RA Capital and 4 more.
- How much funding has Moderna raised?
- Moderna has disclosed $1B raised across 3 of its 5 known rounds.
- Where is Moderna headquartered?
- Moderna is headquartered in Cambridge, US.